PATENT CLAIM ANALYSIS

Application Number: 16004550
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "680000"]

Abstract:
A deacetylnemorone abietane diterpenoid is utilized in the prevention of growth and development of pathogenic cells, e.g., cancer cells. The deacetylnemorone can have the following structure: or a tautomer there of in which R 1 , R 2 , and R 3  are independently selected from —H, C 1-10  alkyl, C 1-10  alkoxy, C 1-10  alkenyl, C 1-10  alkenoxy, —OH, —OAc, —CHO, -Ph, —OC 6 H 5 , —OC 6 H 4 OH, —COC 6 H 5 , —OCONH 2 , —OCONHCH 3 , —OCOC 6 H 4 NH 2 , —NH 2 , or ═O. The deacetylnemorone shows efficacy in treatment and prevention of a wide range of cancer types as well as other neoplastic diseases as a chemo-preventative, a primary or secondary cytotoxic agent, a sensitizer for other therapies, or one component of a combinatorial treatment.

Claim (Index 6):
The method of  claim 1 , wherein the cancer cells comprise breast cancer cells, bladder cancer cells, Kaposi's sarcoma cells, lymphoma cells, ovarian cancer cells, prostate cancer cells, central nervous system cancer cells, renal cancer cells, melanoma cells, colon cancer cells, non-small cell lung cancer cells, or leukemia cells.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 94.0
- Lexical Diversity: 1.86905
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16004538', '16004576', '15286983', '11252966', '15173628']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7143466154496627
- 35 USC 102 Novelty (BERT): 0.5653677452697596
- Combined Prediction Score: 0.6994487284316724
- Mean Citation Score: 239.37299
- Max Citation Score: 423.90723
- Similarity Product: 364.2820864908421

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test